Allogeneic hematopoietic cell transplantation in patients ⩾70 years: which patients may benefit?

Blood Cancer J. 2016 Jul 8;6(7):e443. doi: 10.1038/bcj.2016.54.

Authors

S P Haen^{1

2}, M Pham¹, C Faul¹, D Dörfel¹, W Vogel¹, L Kanz¹, W A Bethge¹

Affiliations

¹ Department for Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany.
² Department for Immunology, Interfacultary Center for Cell Biology, Tuebingen, Germany.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Aged
Comorbidity
Female
Graft vs Host Disease / epidemiology
Graft vs Host Disease / etiology
Hematologic Neoplasms / diagnosis
Hematologic Neoplasms / epidemiology*
Hematologic Neoplasms / therapy*
Hematopoietic Stem Cell Transplantation / adverse effects*
Hematopoietic Stem Cell Transplantation / statistics & numerical data*
Humans
Male
Prognosis
Retrospective Studies
Risk Assessment
Survival Rate
Transplantation, Homologous / adverse effects
Transplantation, Homologous / statistics & numerical data
Treatment Outcome